Close menu

SURE

Sunderland Repository records the research produced by the University of Sunderland including practice-based research and theses.

Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.

Zhen, Tao, Wu, Chuan-Feng, Liu, Ping, Wu, Hai-Yan, Zhou, Guang-Biao, Lu, Ying, Liu, Jian-Xiang, Liang, Yang, Li, Keqin Kathy, Wang, Yue-Ying, Xie, Yin-Yin, He, Miao-Miao, Cao, Huang-Ming, Zhang, Wei-Na, Chen, Li-Min, Petrie, Kevin, Chen, Sai-Juan and Chen, Zhu (2012) Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. Science translational medicine, 4 (127). 127ra38. ISSN 1946-6242

Item Type: Article

Abstract

Nearly 60% of acute myeloid leukemia (AML) patients with the t(8;21)(q22;q22) translocation fail to achieve long-term disease-free survival. Our previous studies demonstrated that oridonin selectively induces apoptosis of t(8;21) leukemia cells and causes cleavage of AML1-ETO oncoprotein resulting from t(8;21), but the underlying mechanisms remain unclear. We show that oridonin interacted with glutathione and thioredoxin/thioredoxin reductase to increase intracellular reactive oxygen species, which in turn activated caspase-3 in t(8;21) cells. Moreover, oridonin bound AML1-ETO, directing the enzymatic cleavage at aspartic acid 188 via caspase-3 to generate a truncated AML1-ETO (ΔAML1-ETO) and preventing the protein from further proteolysis. ΔAML1-ETO interacted with AML1-ETO and interfered with the trans-regulatory functions of remaining AML1-ETO oncoprotein, thus acting as a tumor suppressor that mediates the anti-leukemia effect of oridonin. Furthermore, oridonin inhibited the activity of c-Kit(+) leukemia-initiating cells. Therefore, oridonin is a potential lead compound for molecular target-based therapy of leukemia.

[img]
Preview
PDF
2012 Targeting of AML1-ETO in t(8-21) Leukemia by Oridonin Generates a Tumor Suppressor-Like Protein accepted version.pdf - Accepted Version

Download (2MB) | Preview
[img]
Preview
PDF
2012 Targeting of AML1-ETO in t(8-21) Leukemia by Oridonin Generates a Tumor Suppressor-Like Protein S1.pdf - Supplemental Material

Download (710kB) | Preview

More Information

Depositing User: Kevin Petrie

Identifiers

Item ID: 12435
Identification Number: https://doi.org/10.1126/scitranslmed.3003562
ISSN: 1946-6242
URI: http://sure.sunderland.ac.uk/id/eprint/12435
Official URL: https://stm.sciencemag.org/content/4/127/127ra38.s...

Users with ORCIDS

ORCID for Kevin Petrie: ORCID iD orcid.org/0000-0002-9805-9152

Catalogue record

Date Deposited: 18 Aug 2020 18:02
Last Modified: 30 Sep 2020 10:48

Contributors

Author: Kevin Petrie ORCID iD
Author: Tao Zhen
Author: Chuan-Feng Wu
Author: Ping Liu
Author: Hai-Yan Wu
Author: Guang-Biao Zhou
Author: Ying Lu
Author: Jian-Xiang Liu
Author: Yang Liang
Author: Keqin Kathy Li
Author: Yue-Ying Wang
Author: Yin-Yin Xie
Author: Miao-Miao He
Author: Huang-Ming Cao
Author: Wei-Na Zhang
Author: Li-Min Chen
Author: Sai-Juan Chen
Author: Zhu Chen

University Divisions

Faculty of Health Sciences and Wellbeing > School of Medicine

Subjects

Sciences > Biomedical Sciences
Sciences > Health Sciences

Actions (login required)

View Item View Item